Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

New stocks news | Zytpeptide Biologics has submitted an application to the Hong Kong Stock Exchange. Zweigru Peptide is expected to become the world's first approved monthly dosing GLP-1 RA peptide therapy to be listed on the market.

The Ministry of Justice dropped the case, Powell entered the field, FOMC next week - the countdown to the change of leadership of the Federal Reserve is on, the era of "without forward guidance" is coming.

J.P. Morgan: Although the Middle East issue is unresolved, a negotiation path can be seen, and the macro focus has shifted from risk premium to residual "stagflation" risk.